Insider Trading activities of Enzon Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Enzon Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Enzon Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Enzon Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ENZN. The reporting company's CIK number is 727510.
The total value of stock buying since 2005 is $4,685,669.
The total value of stock sales since 2005 is $7,777,430.
The total value of stock option exercises since 2005 is $4,777,443.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Enzon Pharmaceuticals Inc (ENZN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-11 694,023 $281,079 0 $0 0 $0
2013-09 0 $0 55,926 $96,086 0 $0
2012-08 0 $0 7,753 $51,026 0 $0
2012-06 5,000 $34,395 26,614 $180,483 0 $0
2012-03 0 $0 2,000 $13,842 0 $0
2011-11 0 $0 6,466 $44,218 0 $0
2011-06 0 $0 8,702 $91,980 0 $0
2011-04 0 $0 0 $0 56,040 $0
2011-02 2,000 $21,298 10,000 $108,820 0 $0
2010-11 0 $0 0 $0 11,000 $0
2010-09 0 $0 258,900 $2,762,949 334,200 $2,268,881
2010-08 0 $0 10,000 $104,980 0 $0
2010-07 0 $0 0 $0 12,692 $0
2010-06 0 $0 123,100 $1,385,244 140,800 $1,209,472
2010-05 0 $0 0 $0 18,000 $0
2010-04 0 $0 0 $0 58,770 $0
2010-02 0 $0 251,329 $2,334,934 150,000 $982,500
2009-11 0 $0 0 $0 47,250 $0
2009-09 0 $0 0 $0 15,000 $0
2009-07 0 $0 0 $0 21,395 $0
2009-05 0 $0 0 $0 13,500 $0
2009-04 0 $0 15,791 $96,640 118,200 $0
2009-01 0 $0 10,306 $65,236 0 $0
2008-11 110,000 $378,765 0 $0 47,250 $0
2008-09 0 $0 0 $0 15,000 $0
2008-07 0 $0 0 $0 33,192 $0
2008-05 0 $0 20,487 $194,182 28,500 $111,000
2007-08 65,000 $469,875 0 $0 0 $0
2007-07 131,705 $1,017,413 0 $0 14,160 $0
2007-05 1,000 $8,189 0 $0 0 $0
2007-04 65,553 $539,689 0 $0 0 $0
2007-03 111,552 $917,626 0 $0 0 $0
2007-02 68,910 $600,895 0 $0 0 $0
2007-01 0 $0 0 $0 40,000 $117,480
2006-12 0 $0 30,000 $246,810 30,000 $88,110
2006-07 0 $0 0 $0 7,530 $0
2006-03 40,000 $273,760 0 $0 0 $0
2005-10 12,000 $85,185 0 $0 0 $0
2005-06 10,000 $57,500 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Enzon Pharmaceuticals Inc insiders (ENZN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-11-28 Icahn Carl C Buy 694,023 .41 281,079
2013-09-19 Lebuhn Robert Sale 21,119 1.69 35,627
2013-09-17 Lebuhn Robert Sale 34,807 1.74 60,459
2012-08-14 Lebuhn Robert Sale 5,820 6.58 38,307
2012-08-10 Lebuhn Robert Sale 1,933 6.58 12,719
2012-06-20 Hebard George (Interim PEO and Interim COO) Buy 5,000 6.88 34,395
2012-06-05 Conover Charles (SVP, R&D Program Management) Sale 25,000 6.78 169,500
2012-06-05 Rackear Andrew D. (VP and General Counsel) Sale 1,614 6.80 10,983
2012-03-15 Young Richard A Sale 2,000 6.92 13,842
2011-11-10 Rackear Andrew D. (VP and General Counsel) Sale 3,766 6.68 25,156
2011-11-08 Buchbinder Aby (VP, Clinical Development) Sale 2,700 7.06 19,062
2011-06-01 Lebuhn Robert Sale 8,702 10.57 91,980
2011-04-03 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 12,760 .00 0
2011-04-03 Del Campo Ralph (COO and Princ. Exec. Officer) Option Ex 16,800 .00 0
2011-04-03 Horak Ivan D (EVP, R&D, CSO) Option Ex 26,480 .00 0
2011-02-28 Ogden Mark L (Acting VP of Fin & Prin FO) Buy 2,000 10.65 21,298
2011-02-22 Lebuhn Robert Sale 10,000 10.88 108,820
2010-11-23 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 4,000 .00 0
2010-11-23 Del Campo Ralph (COO and Princ. Exec. Officer) Option Ex 4,000 .00 0
2010-11-23 Horak Ivan D (EVP, R&D, CSO) Option Ex 3,000 .00 0
2010-09-17 Horak Ivan D (EVP, R&D, CSO) Sale 200,000 10.63 2,126,600
2010-09-17 Horak Ivan D (EVP, R&D, CSO) Option Ex 242,000 7.27 1,759,340
2010-09-16 Horak Ivan D (EVP, R&D, CSO) Sale 1,700 10.67 18,132
2010-09-16 Horak Ivan D (EVP, R&D, CSO) Option Ex 2,000 7.14 14,280
2010-09-15 Horak Ivan D (EVP, R&D, CSO) Sale 57,200 10.81 618,217
2010-09-15 Horak Ivan D (EVP, R&D, CSO) Option Ex 70,200 7.05 495,261
2010-09-02 Horak Ivan D (EVP, R&D, CSO) Option Ex 20,000 .00 0
2010-08-26 Lebuhn Robert (Director) Sale 10,000 10.50 104,980
2010-07-02 Micati Victor P (Director) Option Ex 3,173 .00 0
2010-07-02 Salisbury Robert C (Director) Option Ex 3,173 .00 0
2010-07-02 Classon Rolf A (Director) Option Ex 3,173 .00 0
2010-07-02 Lebuhn Robert (Director) Option Ex 3,173 .00 0
2010-06-18 Tooman Craig A (Exec VP Finance, CFO) Sale 123,100 11.25 1,385,244
2010-06-18 Tooman Craig A (Exec VP Finance, CFO) Option Ex 140,800 8.59 1,209,472
2010-05-12 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 6,000 .00 0
2010-05-12 Del Campo Ralph (Chief Operating Officer) Option Ex 6,000 .00 0
2010-05-12 Tooman Craig A (Exec VP Finance, CFO) Option Ex 6,000 .00 0
2010-04-03 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 9,570 .00 0
2010-04-03 Del Campo Ralph (Chief Operating Officer) Option Ex 12,600 .00 0
2010-04-03 Horak Ivan D (President of R&D) Option Ex 19,860 .00 0
2010-04-03 Tooman Craig A (Exec. V.P. Finance, CFO) Option Ex 16,740 .00 0
2010-02-24 Tooman Craig A (Exec. VP Finance, CFO) Sale 150,000 9.27 1,390,650
2010-02-24 Tooman Craig A (Exec. VP Finance, CFO) Option Ex 150,000 6.55 982,500
2010-02-22 Horak Ivan D (EVP, R&D, CSO) Sale 101,329 9.32 944,284
2009-11-23 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 3,000 .00 0
2009-11-23 Del Campo Ralph (EVP-Technical Operations) Option Ex 3,000 .00 0
2009-11-23 Horak Ivan D (EVP, R&D, Chief Sci. Officer) Option Ex 2,250 .00 0
2009-11-23 Tooman Craig A (Exec VP Finance, CFO) Option Ex 3,000 .00 0
2009-11-23 Buchalter Jeffrey H (Chairman, CEO & President) Option Ex 36,000 .00 0
2009-09-02 Horak Ivan D (EVP, R&D, Chief Sci Officer) Option Ex 15,000 .00 0
2009-07-03 Micati Victor P (Director) Option Ex 1,106 .00 0
2009-07-03 Salisbury Robert C (Director) Option Ex 1,106 .00 0
2009-07-03 Ando Goran (Director) Option Ex 1,106 .00 0
2009-07-03 Classon Rolf A (Director) Option Ex 1,106 .00 0
2009-07-03 Lebuhn Robert (Director) Option Ex 1,106 .00 0
2009-07-02 Micati Victor P (Director) Option Ex 3,173 .00 0
2009-07-02 Salisbury Robert C (Director) Option Ex 3,173 .00 0
2009-07-02 Ando Goran (Director) Option Ex 3,173 .00 0
2009-07-02 Classon Rolf A (Director) Option Ex 3,173 .00 0
2009-07-02 Lebuhn Robert (Director) Option Ex 3,173 .00 0
2009-05-12 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 4,500 .00 0
2009-05-12 Del Campo Ralph (EVP, Technical Operations) Option Ex 4,500 .00 0
2009-05-12 Tooman Craig A (Exec VP Finance, CFO) Option Ex 4,500 .00 0
2009-04-03 Davit Paul Stephen (Exec. Vice Pres. HR) Sale 2,826 6.12 17,295
2009-04-03 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 9,570 .00 0
2009-04-03 Del Campo Ralph (EVP, Technical Operations) Option Ex 12,600 .00 0
2009-04-03 Horak Ivan D (EVP, R&D, Chief Scientific Officer) Sale 7,035 6.12 43,054
2009-04-03 Horak Ivan D (EVP, R&D, Chief Scientific Officer) Option Ex 19,860 .00 0
2009-04-03 Tooman Craig A (Exec VP Finance, CFO) Sale 5,930 6.12 36,291
2009-04-03 Tooman Craig A (Exec VP Finance, CFO) Option Ex 16,740 .00 0
2009-04-03 Buchalter Jeffrey H (Chairman of the Board & CEO) Option Ex 59,430 .00 0
2009-01-17 Tooman Craig A (Exec VP Finance, CFO) Sale 10,306 6.33 65,236
2008-11-23 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 3,000 .00 0
2008-11-23 Del Campo Ralph (EVP - Technical Operations) Option Ex 3,000 .00 0
2008-11-23 Horak Ivan D (EVP, R&D, Chief Scientific Officer) Option Ex 2,250 .00 0
2008-11-23 Tooman Craig A (Exec VP Finance, CFO) Option Ex 3,000 .00 0
2008-11-23 Buchalter Jeffrey H (Chairman, CEO & President) Option Ex 36,000 .00 0
2008-11-17 Classon Rolf A (Director) Buy 10,000 4.04 40,400
2008-11-14 Renfro Phillip M (Director) Buy 10,000 3.64 36,400
2008-11-14 Ando Goran (Director) Buy 15,000 3.77 56,505
2008-11-13 Micati Victor P (Director) Buy 15,000 3.28 49,260
2008-11-13 Buchalter Jeffrey H (Chairman, CEO & President) Buy 50,000 3.28 164,000
2008-11-13 Salisbury Robert C (Director) Buy 10,000 3.22 32,200
2008-09-02 Horak Ivan D (EVP, R&D, Chief Scientific Ofc) Option Ex 15,000 .00 0
2008-07-03 Renfro Phillip M (Director) Option Ex 1,105 .00 0
2008-07-03 Micati Victor P (Director) Option Ex 1,105 .00 0
2008-07-03 Ando Goran (Director) Option Ex 1,105 .00 0
2008-07-03 Classon Rolf A (Director) Option Ex 1,105 .00 0
2008-07-03 Lebuhn Robert (Director) Option Ex 1,105 .00 0
2008-07-02 Renfro Phillip M (Director) Option Ex 3,172 .00 0
2008-07-02 Micati Victor P (Director) Option Ex 3,172 .00 0
2008-07-02 Salisbury Robert C (Director) Option Ex 1,105 .00 0
2008-07-02 Ando Goran (Director) Option Ex 3,172 .00 0
2008-07-02 Classon Rolf A (Director) Option Ex 3,172 .00 0
2008-07-02 Lebuhn Robert (Director) Option Ex 3,172 .00 0
2008-07-01 Renfro Phillip M (Director) Option Ex 1,255 .00 0
2008-07-01 Micati Victor P (Director) Option Ex 1,255 .00 0
2008-07-01 Salisbury Robert C (Director) Option Ex 4,427 .00 0
2008-07-01 Ando Goran (Director) Option Ex 1,255 .00 0
2008-07-01 Classon Rolf A (Director) Option Ex 1,255 .00 0
2008-07-01 Lebuhn Robert (Director) Option Ex 1,255 .00 0
2008-05-12 Davit Paul Stephen (Exec. Vice Pres. HR) Option Ex 4,500 .00 0
2008-05-12 Del Campo Ralph (EVP - Technical Operations) Option Ex 4,500 .00 0
2008-05-12 Renfro Phillip M (Director) Sale 15,000 9.48 142,275
2008-05-12 Renfro Phillip M (Director) Option Ex 15,000 7.40 111,000
2008-05-12 Tooman Craig A (Exec VP Finance, CFO) Option Ex 4,500 .00 0
2008-05-09 Renfro Phillip M (Director) Sale 5,487 9.46 51,907
2007-08-20 Buchalter Jeffrey H (Chairman, CEO & President) Buy 5,000 7.46 37,275
2007-08-02 Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) Buy 60,000 7.21 432,600
2007-07-24 Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) Buy 55,000 7.71 424,050
2007-07-16 Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) Buy 22,192 7.75 171,988
2007-07-12 Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) Buy 500 7.71 3,855
2007-07-11 Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) Buy 54,013 7.73 417,520
2007-07-03 Renfro Phillip M (Director) Option Ex 1,105 .00 0
2007-07-03 Micati Victor P (Director) Option Ex 1,105 .00 0
2007-07-03 Salisbury Robert C (Director) Option Ex 1,105 .00 0
2007-07-03 Ando Goran (Director) Option Ex 1,105 .00 0
2007-07-03 Classon Rolf A (Director) Option Ex 1,105 .00 0
2007-07-03 Lebuhn Robert (Director) Option Ex 1,105 .00 0
2007-07-01 Renfro Phillip M (Director) Option Ex 1,255 .00 0
2007-07-01 Micati Victor P (Director) Option Ex 1,255 .00 0
2007-07-01 Salisbury Robert C (Director) Option Ex 1,255 .00 0
2007-07-01 Ando Goran (Director) Option Ex 1,255 .00 0
2007-07-01 Classon Rolf A (Director) Option Ex 1,255 .00 0
2007-07-01 Lebuhn Robert (Director) Option Ex 1,255 .00 0
2007-05-11 Tooman Craig A (Exec VP Finance, CFO) Buy 1,000 8.19 8,189
2007-04-11 Swieca Henry (10% Owner) Buy 10,000 8.25 82,510
2007-04-10 Swieca Henry (10% Owner) Buy 10,253 8.25 84,587
2007-04-09 Swieca Henry (10% Owner) Buy 45,300 8.22 372,592
2007-03-02 Swieca Henry (10% Owner) Buy 111,552 8.23 917,626
2007-02-15 Highbridge Capital Corp (10% Owner) Buy 68,910 8.72 600,895
2007-01-02 Lebuhn Robert (Director) Option Ex 40,000 2.94 117,480
2006-12-11 Classon Rolf A (Director) Sale 30,000 8.23 246,810
2006-12-11 Classon Rolf A (Director) Option Ex 30,000 2.94 88,110
2006-07-01 Renfro Phillip M (Director) Option Ex 1,255 .00 0
2006-07-01 Micati Victor P (Director) Option Ex 1,255 .00 0
2006-07-01 Salisbury Robert C (Director) Option Ex 1,255 .00 0
2006-07-01 Ando Goran (Director) Option Ex 1,255 .00 0
2006-07-01 Classon Rolf A (Director) Option Ex 1,255 .00 0
2006-07-01 Lebuhn Robert (Director) Option Ex 1,255 .00 0
2006-03-07 Horak Ivan D (EVP-R&D & Chief Scien. Officer) Buy 6,000 6.87 41,208
2006-03-07 Tooman Craig A (Exec VP Finance, CFO) Buy 1,000 6.87 6,868
2006-03-07 Buchalter Jeffrey H (Chairman, CEO & President) Buy 20,000 6.84 136,720
2005-10-07 Davit Paul Stephen (Exec. Vice Pres. HR) Buy 6,500 7.03 45,695
2005-10-04 Horak Ivan D (Chief Scien. Officer) Buy 5,500 7.18 39,490
2005-06-10 Buchalter Jeffrey H (Chief Executive Officer) Buy 10,000 5.75 57,500

Insider trading activities including stock purchases, stock sales, and option exercises of ENZN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Enzon Pharmaceuticals Inc (symbol ENZN, CIK number 727510) see the Securities and Exchange Commission (SEC) website.